Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Ayer, Julian

  • Google
  • 2
  • 46
  • 7

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (2/2 displayed)

  • 2023Lessons learnt in the first year of an Australian pediatric cardio oncology clinic2citations
  • 2023Longitudinal cohort study investigating neurodevelopmental and socioemotional outcomes in school-entry aged children after open heart surgery in Australia and New Zealand5citations

Places of action

Chart of shared publication
Gerche, Andre La
1 / 1 shared
Conyers, Rachel
1 / 2 shared
Mateos, Marion K.
1 / 1 shared
Fulbright, Joy
1 / 1 shared
Govender, Dinisha
1 / 1 shared
Lange, Peter W.
1 / 1 shared
Kumar, Sanjeev
1 / 20 shared
Elliott, David A.
1 / 1 shared
Collier, Lane
1 / 1 shared
Eisenstat, David D.
1 / 1 shared
Toro, Claudia
1 / 1 shared
Osullivan, John
1 / 2 shared
Jhadav, Mangesh
1 / 1 shared
Celermajer, David S.
1 / 1 shared
Cheung, Michael
2 / 2 shared
Chart of publication period
2023

Co-Authors (by relevance)

  • Gerche, Andre La
  • Conyers, Rachel
  • Mateos, Marion K.
  • Fulbright, Joy
  • Govender, Dinisha
  • Lange, Peter W.
  • Kumar, Sanjeev
  • Elliott, David A.
  • Collier, Lane
  • Eisenstat, David D.
  • Toro, Claudia
  • Osullivan, John
  • Jhadav, Mangesh
  • Celermajer, David S.
  • Cheung, Michael
OrganizationsLocationPeople

article

Lessons learnt in the first year of an Australian pediatric cardio oncology clinic

  • Gerche, Andre La
  • Conyers, Rachel
  • Mateos, Marion K.
  • Fulbright, Joy
  • Govender, Dinisha
  • Lange, Peter W.
  • Kumar, Sanjeev
  • Elliott, David A.
  • Collier, Lane
  • Ayer, Julian
  • Eisenstat, David D.
  • Toro, Claudia
  • Osullivan, John
  • Jhadav, Mangesh
  • Celermajer, David S.
  • Cheung, Michael
Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Modern oncological therapies together with chemotherapy and radiotherapy have broadened the agents that can cause cardiac sequelae, which can manifest for pediatric oncology patients while on active treatment. Recommendations for high-risk patients who should be monitored in a pediatric cardio-oncology clinic have previously been developed by expert Delphi consensus by our group. In 2022 we opened our first multidisciplinary pediatric cardio-oncology clinic adhering to these recommendations in surveillance and management.</jats:p></jats:sec><jats:sec><jats:title>Objectives</jats:title><jats:p>Our pediatric cardio-oncology clinic aimed to:</jats:p><jats:p>(i) Document cardiovascular toxicities observed within a pediatric cardio-oncology clinic and.</jats:p><jats:p>(ii) Evaluate the applicability of the Australian and New Zealand Pediatric Cardio-Oncology recommendations.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Monthly multidisciplinary cardio-oncology clinics were conducted in an Australian tertiary pediatric hospital. Structured standardised approaches to assessment were built into the electronic medical record (EMR). All patients underwent baseline echocardiogram and electrocardiogram assessment together with vital signs in conjunction with standard history and examination.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Nineteen (54%) individuals had a documented cardiovascular toxicity or pre-existing risk factor prior to referral. The two most common cardiovascular toxicities documented during clinic review included Left Ventricular Dysfunction (LVD) and hypertension. Of note 3 (8.1%) patients had CTCAE grade III LVD. An additional 10 (27%) patients reviewed in clinic had CTCAE grade I hypertension. None of these patients had hypertension noted within their referral. Cascade testing for cardiac history was warranted in 2 (5.4%) of patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Pediatric cardio-oncology clinics are likely beneficial to documenting previously unrecognised cardiotoxicity and relevant cardiac family histories, whilst providing an opportunity to address lifestyle risk factors.</jats:p></jats:sec>

Topics
  • toxicity
  • size-exclusion chromatography
  • electron magnetic resonance spectroscopy